Boston Scientific Co. (NASDAQ: BSX) Stocks Generating Improved Relative Strength

Boston Scientific Co. day trading at USD 35.52 per share, then rallying to 36.13 and closing at USD 34.79 per share. A net loss of -2.55% for the day. Long term pricing analysis shows the stock trading at 22.51% lower than it’s 52week high and -42.94% higher than the 52week low. The share volume traded for the day was 8,270K which was 0 times the 50 Day Average Volume.

Boston Scientific Co. had a market cap of 50,271,653K as of 21st May 2020. The Earnings Per Share (EPS) for Q4 2019 is $ 3.04.

Boston Scientific Co. doing business as Boston Scientific is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology, and gynecology.

Financial Results

Boston Scientific Co. Fourth Quarter Of Fiscal 2019.

  • Reported fourth-quarter sales of $2.905 billion, representing an increase of 13.4 percent on a reported basis, compared to the company’s guidance range of 13 to 15 percent; 14.1 percent on an operational basis; and 7.3 percent on an organic basis, compared to the company’s guidance range of 8 to 9 percent, all compared to the prior-year period.
  • Reported fourth-quarter GAAP earnings of $2.83 per share, compared to the company’s guidance range of $0.22 to $0.25 per share.
  • Reported GAAP earnings include net litigation charges of $169 million, or $0.12 per share, primarily related to the previously disclosed Channel Medsystems, Inc. matter, and a net income tax benefit of $4.102 billion, or $2.90 per share.

Boston Scientific Co.(21st May 2020): The Institutional Ownership as of today stood at 91.91% and the Total Value of Holdings (millions) is $ 44,746.

New Institutional Holders and other activity – As of today the total number of shares held are 1,286,160,336 by 927 institutional holders.

LATEST NEWS:

22-May-2020:-  Cetera Advisor Networks LLC Buys 973 Shares of Boston Scientific Co. (NYSE: BSX)

Cetera Advisor Networks LLC boosted its holdings in Boston Scientific Co. (NYSE: BSX) by 3.2% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 31,118 shares of the medical equipment provider’s stock after purchasing an additional 973 shares during the quarter.

21-May-2020:-  Oppenheimer Asset Management Inc. Purchases 14,669 Shares of Boston Scientific Co. (NYSE: BSX)

Oppenheimer Asset Management Inc. increased its position in Boston Scientific Co. (NYSE: BSX) by 27.3% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 68,455 shares of the medical equipment provider’s stock after acquiring an additional 14,669 shares during the quarter.

19-May-2020:-  Aigen Investment Management LP Takes $4.85 Million Position in Boston Scientific Co. (NYSE: BSX)

Aigen Investment Management LP purchased a new stake in shares of Boston Scientific Co. (NYSE: BSX) during the 1st quarter, HoldingsChannel.com reports. The fund purchased 148,603 shares of the medical equipment provider’s stock, valued at approximately $4,849,000.

Leave a Reply

Your email address will not be published. Required fields are marked *